Main > ENDOCRINOLOGY > SE/UK. A. Diab. 1>Dapagliflozin

---

SE/UK. A. Diab. 1>Dapagliflozin's subsections
(*) EU Approval Date: 2019. 03.25.
Company
Mechanism: SGLT2 Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 11
Patent>UpDate: 2019. 10.22
TradeMark
TradeMark Web-Site

SE/UK. A. Diab. 1>Dapagliflozin's products
This section has no products